MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$30,218K
Interest income
$2,698K
Net loss
-$29,634K
Deemed dividend to
preferred stockholders
$584K
Total other income
(expense), net
$940K
Revenue
$50,511K
Interest expense
$1,430K
Change in fair value of
warrant liabilities
$328K
Loss from operations
-$30,574K
Gross profit
$38,040K
Cost of sales
$12,471K
Total operating
expenses
$68,614K
Sales and marketing
$35,027K
Research and development
$17,019K
General and
administrative
$16,568K
Back
Back
Income Statement
source: myfinsight.com
CARLSMED, INC. (CARL)
CARLSMED, INC. (CARL)